Effect of Nitric Oxide Donors on Blood Pressure and Pulse Pressure in Acute and Subacute Stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 15, Issue 6, 2006, Pages 245-249

  Gray, Laura J ^a   Sprigg, Nikola ^a   Rashid, Parveen A ^b   Willmot, Mark R ^a   Bath, Philip M W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Raddcliffe Infirmary   (United Kingdom)

Author keywords

Acute stroke; blood pressure; glyceryl trinitrate; heart rate; pulse pressure

Indexed keywords

GLYCERYL TRINITRATE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM;

ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; COCHRANE LIBRARY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; EMBASE; HEART RATE; HEMODYNAMICS; HUMAN; MEAN ARTERIAL PRESSURE; MEDLINE; PRIORITY JOURNAL; PULSE PRESSURE; STROKE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 33750740396     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2006.06.002     Document Type: Article

References (24)

1. Leonardi-Bee J., Bath P.M.W., Phillips S.J., et al., IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 33 (2002) 1315-1320
2. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002) 1903-1913
3. Gray L.J., Sprigg N., and Bath P.M.W. Relationship between functional outcome and baseline blood pressure, pulse pressure and heart rate in acute ischaemic stroke: data from the TAIST trial [abstract]. Cerebrovasc Dis 19 Suppl 2 (2005) 36
4. Robinson T.G., Dawson S.L., Ahmed U., et al. Twenty-four-hour systolic blood pressure predicts long-term mortality following acute stroke. J Hypertens 19 (2001) 2127-2134
5. Steger C., Pratter A., Martinek-Bregel M., et al. Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry. Eur Heart J 25 (2004) 1734-1740
6. Scandinavian Candesartan Acute Stroke Trial (SCAST). The Trial. Available at http://www.scast.no/resource.asp. Accessed July 31, 2006.
7. Bath P.M. Major ongoing stroke trials. Efficacy of Nitric Oxide in Stroke (ENOS) trial [abstract]. Stroke 32 (2001) 2450-2451
8. The CHHIPS Trial Group. CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) Pilot Trial: rationale and design. J Hypertens 23 (2005) 649-655
9. Willmot M.R., and Bath P.M.W. The potential of nitric oxide therapeutics in stroke. Exp Opin Invest Drugs 12 (2003) 455-470
10. Willmot M., Gray L., Gibson C., et al. A systematic review of nitric oxide donors and L-arginine in experimental stroke: effects on infarct size and cerebral blood flow. Nitric Oxide 12 (2005) 141-149
11. Bath P.M.W., Pathansali R., Iddenden R., et al. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc Dis 11 (2001) 265-272
12. Rashid P., Weaver C., Leonardi-Bee J.A., et al. The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac haemodynamics and plasma nitric oxide levels in acute stroke. J Stroke Cerebrovasc Dis 13 (2003) 143-151
13. Willmot M., Ghadami A., Whysall B., et al. Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension 47 (2006) 1209-1215
14. Bath P.M.W., Willmot M., and Bath F.J. Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors in acute ischaemic stroke [Cochrane review]. The Cochrane Library (2002), Update Software, Oxford issue 3
15. Moher D., Jadad A.R., Nichol G., et al. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 16 (1995) 62-73
16. Butterworth R.J., Cluckie A., Jackson S.H.D., et al. Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis 8 (1998) 158-165
17. Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Introduction available at http://www.thegeorgeinstitute.org/iih/index.cfm?F7EA9EB3-D7A8-D98F-DF82-743045749620. Accessed July 31, 2006.
18. Blood Pressure in Acute Stroke Collaboration (BASC). Interventions for deliberately altering blood pressure in acute stroke [Cochrane review]. Cochrane Database Syst Rev 4 (2001)
19. Barer D.H., Cruickshank J.M., Ebrahim S.B., et al. Low-dose beta blockade in acute stroke (BEST trial): an evaluation. BMJ 296 (1988) 737-741
20. Ahmed N., Nasman P., and Wahlgren N.G. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 31 (2000) 1250-1255
21. International Society of Hypertension Writing Group. International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens 21 (2003) 665-672
22. Pickering T.G., Hall J.E., Appel L.J., et al. Recommendations for blood pressure measurement in humans and experimental animals. Part 1, blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the AHA Council on HBP. Circulation 111 (2005) 697-716
23. Robinson T., Waddington A., Ward-Close S., et al. The predictive role of 24-hour compared to casual blood pressure levels on outcome following acute stroke. Cerebrovasc Dis 7 (1997) 264-272
24. O'Brien E., Beevers G., and Lip G.Y. ABCs of hypertension: blood pressure measurement. Part III, automated sphygmomanometry: ambulatory blood pressure measurement. BMJ 322 (2001) 1110-1114